Antibody

In 2023, the world spent over $200 billion on antibody drugs — treatments like Keytruda for cancer and Humira for autoimmune disease. But finding a single antibody that binds well enough to become a drug is like searching for a specific grain of sand on a beach. A typical drug discovery campaign screens thousands of candidates, each one requiring expensive lab tests to measure how tightly it grabs its target. Most fail.